NCT06322667View on ClinicalTrials.gov

A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Alzheimer's Disease
Interventions
OTHER

No Intervention

This is a non-interventional study.

Trial Locations (3)

Unknown

RECRUITING

Eisai trial site 2, Hiroshima

RECRUITING

Eisai trial site 3, Kyoto

RECRUITING

Eisai trial site 1, Tokyo

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY